Mustang Bio to Participate in Three September 2021 Investor Conferences

On September 9, 2021 Mustang Bio, Inc. ("Mustang") (NASDAQ: MBIO), a clinical-stage biopharmaceutical company focused on translating today’s medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors and rare genetic diseases, reported that Manuel Litchman, M.D., President and Chief Executive Officer, will participate in three virtual investor conferences in September 2021b (Press release, Mustang Bio, SEP 9, 2021, View Source [SID1234587540]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Details of the events are as follows:

H.C. Wainwright 23rd Annual Global Investment Conference: The company’s presentation will be available for on-demand viewing on Mustang’s website beginning on Monday, September 13, 2021, at 7:00 a.m. ET and will remain available on the Events page of the Investor Relations section of Mustang’s website, www.mustangbio.com, for approximately 30 days after the meeting. The company will participate in one-on-one meetings during the conference as well.
Oppenheimer Fall Healthcare Life Sciences & MedTech Summit: The company will participate in a fireside chat on Monday, September 20, 2021, at 12:25 p.m. ET and will participate in one-on-one meetings during the conference. A webcast of the company’s chat will be available on the Events page of the Investor Relations section of Mustang’s website, www.mustangbio.com, for approximately 30 days after the meeting.
Cantor Global Healthcare Conference: The company will participate in a fireside chat on Monday, September 27, 2021, at 10:40 a.m. ET and will participate in one-on-one meetings during the conference. A webcast of the company’s chat will be available on the Events page of the Investor Relations section of Mustang’s website, www.mustangbio.com, for approximately 30 days after the meeting.